Bernard J. Cassidy is the Executive Vice President, General Counsel, and Corporate Secretary at SANA BIOTECHNOLOGY INC, a leading biotechnology firm focused on developing innovative therapies for a wide range of diseases. With over two decades of experience in the legal and biotechnology sectors, Cassidy has played a pivotal role in guiding SANA BIOTECHNOLOGY INC through complex regulatory landscapes and intellectual property challenges. His strategic vision and deep understanding of the biotech industry have been instrumental in driving the company's growth and success. Prior to joining SANA BIOTECHNOLOGY INC, Cassidy held several high-profile positions at other biotech companies, where he honed his skills in corporate governance, compliance, and mergers and acquisitions. His career also includes a stint at a top-tier law firm, where he specialized in life sciences and represented numerous biotech clients. Cassidy's achievements include successfully navigating multiple FDA approvals for new therapies and leading negotiations for significant partnerships and acquisitions that have expanded SANA BIOTECHNOLOGY INC's portfolio and market reach. In his current role at SANA BIOTECHNOLOGY INC, Cassidy oversees all legal affairs, ensuring that the company adheres to the highest standards of corporate governance and regulatory compliance. He works closely with the executive team to develop and implement strategies that align with the company's mission to advance healthcare through cutting-edge biotechnology. Cassidy's leadership and expertise continue to be vital assets as SANA BIOTECHNOLOGY INC strives to bring transformative treatments to patients worldwide.